News & Perspective

Oct 29, 2008

Oct 29, 2008

Experts stress vigilance over emerging, unpredictable diseases

See related article posted today: "US urged to launch major campaign against emerging diseases"

– WASHINGTON, DC (CIDRAP News) – Health authorities must remain alert to new and renascent disease threats, experts warned this week at an international medical meeting.

Oct 28, 2008

Oct 28, 2008

Fifth case confirmed in South African viral outbreak

(CIDRAP News) – A fifth case has been confirmed in the recent outbreak of febrile illnesses caused by a mysterious virus in South Africa, and preliminary tests have supported earlier suspicions that it is new member of the arenavirus family, South African health officials announced recently.

Oct 21, 2008

Oct 21, 2008

Google funds projects to find, fight new pathogens

(CIDRAP News) – The philanthropic arm of the Internet search company Google today announced it is awarding more than $14 million for various projects aiming to prevent the next pandemic by detecting new pathogens and disease outbreaks in Africa and Southeast Asia.

Oct 13, 2008

Oct 13, 2008

Tests indicate an arenavirus in South African deaths

(CIDRAP News) – The World Health Organization (WHO) said today that preliminary tests indicate that an arenavirus—possibly a previously unknown one—is responsible for the mysterious febrile disease that killed three people in South Africa and has now sickened a fourth.

Oct 10, 2008

Oct 10, 2008

WHO: Mystery fever killed three in South Africa

(CIDRAP News) – The World Health Organization (WHO) today said a mysterious febrile disease that bears some resemblance to a viral hemorrhagic fever (VHF) has killed three people in Johannesburg, South Africa.

The WHO said the victims so far have tested negative for several VHFs and other infectious diseases, and no new cases have emerged since the latest death on Oct 5.

Oct 08, 2008

Oct 08, 2008

Two firms win NIAID support for Ebola-Marburg vaccines

(CIDRAP News) – Two biotechnology companies—Crucell, based in the Netherlands, and Integrated BioTherapeutics, based in Germantown, Md.—recently announced that they have received $30 million and $22 million contracts, respectively, from the National Institutes of Allergy and Infectious Diseases (NIAID) to develop single vaccines that would protect against both Ebola and Marburg viruses.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»